Avatrombopag, an oral thrombopoietin receptor agonist: results of two double ‐blind, dose‐rising, placebo‐controlled Phase 1 studies

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - September 11, 2018 Category: Hematology Authors: David J. Kuter , Lee F. Allen Source Type: research